Avience Biomedicals Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 253.15 as of 30 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2024 .The P/E Ratio of Global Longlife Hospital and Research Ltd is 0 as of March 2024 . The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Global Longlife Hospital and Research Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution in Ahmedabad.
Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

FAQs for the comparison of Avience Biomedicals Ltd and Global Longlife Hospital and Research Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Global Longlife Hospital and Research Ltd?

Market cap of Avience Biomedicals Ltd is 138 Cr while Market cap of Global Longlife Hospital and Research Ltd is 13 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Global Longlife Hospital and Research Ltd?

The stock performance of Avience Biomedicals Ltd and Global Longlife Hospital and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Global Longlife Hospital and Research Ltd?

As of November 1, 2026, the Avience Biomedicals Ltd stock price is INR ₹253.15. On the other hand, Global Longlife Hospital and Research Ltd stock price is INR ₹12.82.

How do dividend payouts of Avience Biomedicals Ltd and Global Longlife Hospital and Research Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Global Longlife Hospital and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.